Brivudine - direct healthcare professional communication (DHPC)

About

This direct healthcare professional communication (DHPC) contains important information for healthcare professionals prescribing, dispensing or administering the medicine(s). It also includes a communication plan with details of intended recipients and the dissemination date.

Documents

Direct healthcare professional communication (DHPC): Brivudine: potentially fatal toxicity of fluoropyrimidines if administered shortly before or at the same time with brivudine or used within 4 weeks after the end of treatment with brivudine

Dissemination date: 12/05/2020Summary:

Direct healthcare professional communication (DHPC)

Key facts

• Active substance:
  Brivudine
• Procedure number:
  PSUSA/00000434/201907
• Regulatory outcome:
  Variation
• DHPC type:
  Periodic safety update single assessment
• Human ATC codes:
  J05AB15
• Dissemination date:
  12/05/2020